Latest work by Prof. Uri Samuni (Queens College) & collaborators presents a new class of prostate-specific membrane antigen (PSMA)-targeting peptides for selective small interfering RNA (siRNA) delivery in prostate cancer (PCa) cells.
Read in the Molecular Therapy Family Of Journals: https://bit.ly/2P7UJGh
![](https://i0.wp.com/cunychemphd.commons.gc.cuny.edu/wp-content/blogs.dir/3411/files/2019/12/uri.jpg?resize=525%2C255&ssl=1)